← All organizations

Titan Pharmaceuticals

For profit

Also known as: Titan Pharmaceuticals | TITAN PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Oct 10, 2017

Timeline

1990s

Jan 1, 1992
Titan Pharmaceuticals— Founded

2010s

May 26, 2016
buprenorphine— NDA Secondary Org

Drugs by trial phase (7 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

buprenorphine

Phase 2 (6 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

buprenorphine

Recent trials (12)

NCT03250117Study directorPhase 1/Phase 2Oct 10, 2017
NCT03250117Lead sponsorPhase 1/Phase 2Oct 10, 2017
NCT01262261Overall official - principal investigatorPhase 3Nov 1, 2010
NCT01114308Lead sponsorPhase 3Apr 30, 2010
NCT01114308Overall official - principal investigatorPhase 3Apr 30, 2010
NCT00103519Lead sponsorPhase 2Dec 1, 2004
NCT00083473Lead sponsorPhase 2May 1, 2004
NCT00087477Lead sponsorPhase 1/Phase 2Jan 1, 2004
NCT00073385Lead sponsorPhase 2Sep 1, 2003
NCT00206687CollaboratorPhase 2Jan 1, 2003
NCT00050687Lead sponsorPhase 1/Phase 2Jun 1, 2001
NCT00761436CollaboratorPhase 2Feb 1, 2000

Details

Founded: South San Francisco, CA, US Jan 1, 1992
Last known activity: Oct 10, 2017